IFNG and neoplasm: In order to assess whether tumors induced by IFN-γ non-responsive tumor cells may be sensitive to PD-1/PD-L1 blockade and simultaneously enhance the efficacy of immunotherapy of tumors induced by such cells, we prepared TC-1 and TC-1/A9 clones with a deactivated IFN-γ receptor.